Scott Randal W.

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$6.2M
Insider Sells Quantity
6
Insider Sells Sum
$389,292.52

Insider Activity of Scott Randal W.

According to the SEC Form 4 filings, Scott Randal W., being in a position of

  1. director at BridgeBio Pharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5000 shares for $160,793,
    over all time since 2021-02-17, has bought 16000 shares for $1M, and sold 12000 shares for $389,293.

The largest purchase of all time was on 2021-02-17 and amounted to 312500 shares of Talis Biomedical Corporation for $5M.

The largest sale of all time was on 2024-03-01 and amounted to 2500 shares of BridgeBio Pharma, Inc. for $85,000.

Biography of Scott Randal W.

No biography is available at this moment.

2024-06-04SaleBridgeBio Pharma, Inc.
BBIO
director
1,500
0.0009%
$31.30$46,950-3.57%
2024-06-03SaleBridgeBio Pharma, Inc.
BBIO
director
1,000
0.0005%
$28.84$28,843-9.66%
2024-03-01SaleBridgeBio Pharma, Inc.
BBIO
director
2,500
0.0014%
$34.00$85,000-24.17%
2023-12-18SaleBridgeBio Pharma, Inc.
BBIO
director
2,000
0.0012%
$40.00$80,000-27.58%
2023-12-01SaleBridgeBio Pharma, Inc.
BBIO
director
2,500
0.0014%
$29.40$73,500-8.44%
2023-09-05SaleBridgeBio Pharma, Inc.
BBIO
director
2,500
0.0016%
$30.00$75,000-3.76%
2021-05-17PurchaseTalis Biomedical Corporation
TLIS
director
11,000
0.0426%
$10.11$111,210-51.03%
2021-05-14PurchaseTalis Biomedical Corporation
TLIS
director
9,000
0.0354%
$10.16$91,440-47.52%
2021-02-17PurchaseBridgeBio Pharma, Inc.
BBIO
director
16,000
0.0111%
$62.50$1M-21.37%
2021-02-17PurchaseTalis Biomedical Corporation
TLIS
director
312,500
1.5752%
$16.00$5M-65.14%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.